Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Carl-Michael Staschen

Nonclinical Pharmacokinetics and Activity of Etirinotecan Pegol (NKTR-102), a Long-Acting Topoisomerase 1 Inhibitor, in Multiple Cancer Models

Cancer Chemotherapy and Pharmacology

English

Related publications

Bioavailability and Pharmacokinetics of Oral Topotecan: A New Topoisomerase I Inhibitor

British Journal of Cancer

Cancer Research

Oncology

1996

English

Effects of a Specific and Long-Acting Renin Inhibitor in the Marmoset

Hypertension

Internal Medicine

1985

English

Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2010

English

Improvement of the Pharmacokinetics and in Vivo Antibacterial Efficacy of a Novel Type IIa Topoisomerase Inhibitor by Formulation in Liposomes

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2013

English

Opicapone: A Short Lived and Very Long Acting Novel Catechol-O-Methyltransferase Inhibitor Following Multiple Dose Administration in Healthy Subjects

British Journal of Clinical Pharmacology

Pharmacology

2013

English

Pharmacokinetics in Rats of a Long-Acting Human Parathyroid Hormone–Collagen Binding Domain Peptide Construct

Journal of Pharmaceutical Sciences

Pharmaceutical Science

2014

English

Pharmacokinetics, Immunogenicity, Safety and Preliminary Efficacy of Subcutaneous Turoctocog Alfa Pegol in Previously Treated Patients With Severe Hemophilia a (Alleviate 1)

Journal of Thrombosis and Haemostasis

Medicine

Hematology

2019

English

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity After a Single Administration

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2010

English

Synergistic Activity of the mTOR Inhibitor Ridaforolimus and the Antiandrogen Bicalutamide in Prostate Cancer Models

International Journal of Oncology

Cancer Research

Oncology

2012

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Carl-Michael Staschen

Nonclinical Pharmacokinetics and Activity of Etirinotecan Pegol (NKTR-102), a Long-Acting Topoisomerase 1 Inhibitor, in Multiple Cancer Models

Related publications

Bioavailability and Pharmacokinetics of Oral Topotecan: A New Topoisomerase I Inhibitor

Effects of a Specific and Long-Acting Renin Inhibitor in the Marmoset

Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation

Improvement of the Pharmacokinetics and in Vivo Antibacterial Efficacy of a Novel Type IIa Topoisomerase Inhibitor by Formulation in Liposomes

Opicapone: A Short Lived and Very Long Acting Novel Catechol-O-Methyltransferase Inhibitor Following Multiple Dose Administration in Healthy Subjects

Pharmacokinetics in Rats of a Long-Acting Human Parathyroid Hormone–Collagen Binding Domain Peptide Construct

Pharmacokinetics, Immunogenicity, Safety and Preliminary Efficacy of Subcutaneous Turoctocog Alfa Pegol in Previously Treated Patients With Severe Hemophilia a (Alleviate 1)

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity After a Single Administration

Synergistic Activity of the mTOR Inhibitor Ridaforolimus and the Antiandrogen Bicalutamide in Prostate Cancer Models